Cardiometabolic Changes After Continuous Positive Airway Pressure Treatment For Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$82,421.00
Summary
CPAP is the preferred treatment for patients with OSA because of its well-proven ability to decrease sleepiness and improve blood pressure control. This study will definitively establish if CPAP can also improve markers of cardio-metabolic health, such as visceral fat, insulin sensitivity, central blood pressure and arterial stiffness. The results of the study will shed light on the broader health consequences of OSA and contributes to the development of more targeted treatment strategies.
Metabolic And Neurobiological Changes After Continuous Positive Airway Pressure Treatment For Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$503,497.00
Summary
CPAP is the preferred treatment for patients with OSA because of its well-proven ability to decrease sleepiness and improve blood pressure control. This study will definitively establish if CPAP can also improve markers of cardio-metabolic health, such as visceral fat, insulin sensitivity, central blood pressure and arterial stiffness. The results of the study will shed light on the broader health consequences of OSA and contribute to the development of more targeted treatment strategies.
The Role Of Arousal In The Pathogenesis Of Obstructive Sleep Apnea And Implications For Novel Therapeutic Treatments
Funder
National Health and Medical Research Council
Funding Amount
$297,888.00
Summary
This research forms part of a series of studies aimed at characterizing the relative importance of the various physiological causes (phenotypes) of obstructive sleep apnea (OSA) and has the potential to lead to individually tailored novel therapies according to these traits. Specifically, this proposed research will investigate the role of arousal from sleep (brief awakening) in OSA and explore methods of manipulating the arousal threshold as a new treatment approach for certain OSA patients.